Veracyte reported $67K in Ordinary Share Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Agenus AGEN:US $ 2.25M 0.07M
Agilent A:US $ 3M 0M
Anika Therapeutics ANIK:US $ 0.14M 0M
Arrowhead Research ARWR:US $ 197K 1000
Biocept BIOC:US $ 0M 0M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Exact Sciences EXAS:US $ 1.72M 0.01M
Genmark Diagnostics GNMK:US $ 0.01M 0M
Heron Therapeutics HRTX:US $ 1.02M 0.1M
Illumina ILMN:US $ 2M 0M
Immunogen IMGN:US $ 2M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Laboratory Of America LH:US $ 8.9M 0.1M
Luminex LMNX:US $ 0.05M 0M
Myriad Genetics MYGN:US $ 0.8M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.45M 0.01M
Siemens SIE:GR € 2550M 0M
Sonic Healthcare SHL:AU $ 4.08B 3.79M
Veracyte VCYT:US $ 0.07M 0M